Bing

SEARCH HISTORY

Hologic Inc. (NASDAQ:HOLX - News) is currently up (+24.86%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. To find out what other Investors are saying …
Finance Yahoo · 11/22/2013
That is far below the 50-day average of 2.38 million shares, but it will add to the overall volatility in the stock. The consensus price target is a whopping $80.67. Shares ended Thursday at $43.04. Hologic Inc. (NASDAQ: HOLX) is a health care stock that ...
24/7 Wall ST · 10/3/2014
Synageva Biopharma Corp. (NASDAQ: GEVA): Heberlig Chris sold 7,500 stocks at $103.02. Hologic (NASDAQ: HOLX): Crawford Sally sold 17,881 stocks at $32.00. Healthstream (NASDAQ: HSTM): Dent Thompson sold 13,700 stocks at $25.68. Illumina …
Fx Pips · 3/16/2015
More from Bing News
In a report published Monday, Morgan Stanley analyst David Lewis downgraded Hologic (NASDAQ: HOLX) from Overweight to Equal-weight and removed their $22.00 price target. Although there is a balanced risk-reward following recent stock appreciation ...
Benzinga · 1/6/2014
it's not a bad idea to take a closer look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense. What: Shares of Hologic (NASDAQ: HOLX ) sank 3% this morning after BTIG downgraded the ...
The Motley Fool · 7/7/2014
Hologic (HOLX), the maker of women's medical diagnostic equipment, dropped a bomb in announcing its new product would be delayed. The stock is off about 20% today. For holders of the company's 2% convertible bonds, though, this might actually turn …
Minyanville · 5/5/2009
June 18, 2015 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today that it has priced its previously ... conditions or circumstances on which any such statements are based. Stock Market XML and JSON Data API provided by FinancialContent …
Financial Content · 6/19/2015
Notes Due
Agenus Inc. (AGEN)’S monthly performance stands at 17.83% with an analyst rating of 2.00 (Click To Expand Current Stock Data:) Biocept, Inc. (BIOC) of the Healthcare sector (Medical Laboratories & Research) has changed by -0.63% ( -3.98% since …
wallstreetscope.com · 4/23/2015
Our latest featured buy-rated stock develops and manufactures diagnostic and medical ... a leading research firm known for its independence from Wall Street. Hologic, Inc. (HOLX) focuses on osteoporosis assessment, breast-cancer detection, direct capture ...
The Money Show · 5/29/2015
The analyst also cited rising free cash flow and lower interest expense. Khanna said the stock is oversold at 8 times price-to-earnings (i.e., 24%, which less than peers) despite an estimated 2010 EPS upturn. Khanna sees a 3-to-1 risk/reward over one year.
Bloomberg · 5/5/2009